Brolucizumab Antibody
Brolucizumab (DLX1008) is a high-affinity, single-chain anti-VEGF-A antibody fragment for research. It potently inhibits VEGF-A to suppress pathological angiogenesis and vascular permeability, supporting in vitro and in vivo studies in ophthalmology, particularly for neovascular age-related macular degeneration (AMD) .
Product Specifications
Product Name Alternative
RTH258, ESBA 1008, DLX1008
Target
VEGFR
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Concentration
13.166 mg/mL
Purity
≥95% (May vary between batches)
Molecular Weight
~150 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![(9Z)-N-[2-(4-Hydroxyphenyl)ethyl]-9-octadecenamide](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
TRC-H405190-750MG 750 mg
(9Z)-N-[2-(4-Hydroxyphenyl)ethyl]-9-octadecenamide
Sign In for Pricing
View Details 
MBS625359-01 0.1 mL
Epidermal Growth Factor Receptor, phosphorylated (Tyr1045) (erbB, EGFR)
Sign In for Pricing
View Details MBS625359-02 5x 0.1 mL
Epidermal Growth Factor Receptor, phosphorylated (Tyr1045) (erbB, EGFR)
Sign In for Pricing
View Details 